PMD is #MakingEveryBreathCount improving patient outcomes & safety with RespiraSense, a revolutionary sensor platform for continuous respiratory rate monitoring

COVID-19 Critical Care

Continuous respiratory rate monitoring of COVID-19 patients can reduce patient contact, accurately track respiratory rate, give early indication of deterioration, and help to improve patient outcomes.

Remote wireless continuous respiratory rate monitoring  protects the clinician and maintains the integrity of the isolation area

RespiraSense provides real-time objective respiratory rate data which shows on a “central station” dashboard at the nurses’ station with a graphic and audible alarm when the respiratory rate is outside the specified range for a patient. This means that potential deterioration can be quickly identified.

The right treatment at the right time

The nurse or doctor can then go to the patient and from a distance of up to 10 metres, review respiratory rate trends, allowing for quick intervention as necessary without the need to change PPE.

RespiraSense data allows for precision care based on rapid, real-time response to significant clinical changes.

RespiraSense has shown through Danish studies that it can detect deterioration from pulmonary oedema 6-12 hours earlier than the standard of care and before other vital signs begin to indicate distress.

Remote respiratory rate monitoring with RespiraSense improves the accuracy and timing of respiration rate recording, allowing for precise interventions based upon the recognised earliest sign of deterioration, while relieving demand for scarce critical care equipment.

RESPIRATORY RATE > 27 BREATHS PER MINUTE IS THE MOST IMPORTANT PREDICTOR OF PATIENT DETERIORATION

RepiraSense Continuous Respiratory Rate Monitoring gives medical professionals the confidence to know that future escalations in care can be prevented due to the continuous and non-invasive monitoring of patients’ respiratory rate while with minimal patient contact.

The innovative, discrete device is ideally designed for COVID-19 patients who are at a risk of adverse events. It is proven to greatly improve patient care and clinical outcome, allowing consultants and nurses alike to develop more accurate early warning scores.

It is widely regarded that relative changes in a patient’s respiratory rate is the most sensitive and specific prediction of health deterioration:

  • Respiratory rate > 27 BPM (Breaths Per Minute) is the most important predictor of Cardiac Arrest
  • 50% of patients with RR >24 BPM suffer serious adverse events
  • 21% of patients with 25 ≤ RR ≥ 29 BPM died.

The innovative sensor technology ensures better patient care.

  • Predicts future escalations in patient care
  • Allows for early intervention
  • Easy to use
  • Discrete and patient friendly
  • Provides better long-term patient outcomes.